Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial
Huvudupphovsmän: | , , , , , , , , , , , |
---|---|
Materialtyp: | Conference item |
Publicerad: |
2010
|
Sammanfattning: |
---|